Consumerism in Healthcare

Stop Clopez Corp voluntarily recalls herbal dietary supplement

April 26, 2024 - On April 23, 2024, the United States FDA published a voluntary recall from Stop Clopex Corp regarding its Schwinnng capsules. According to the recall, the product was found to contain Nortadalafil, an active drug ingredient, during an FDA analysis. Dietary supplements are only loosely regulated across the United States. Unlike pharmaceutical...


More Articles

Comparing Global Pharmaceutical Markets: US, UK, and China

by Veronica Salib

As the COVID-19 pandemic has progressed over the last three years, the global pharmaceutical landscape has had to evolve to keep up with growing demands. While the worldwide landscape has continued to change and grow, so have the...

J&J Preps for Consumer Health Spin-Off, Purchases Abiomed for $16.6B

by Hayden Schmidt

Pharmaceutical company Johnson & Johnson struck a deal Tuesday to acquire Abiomed, the heart pump manufacturer. J&J will pay $16.6 billion in cash for the acquisition, valuing the stock at $380...

GSK Introduces Standalone Consumer Healthcare Company, Haleon

by Samantha McGrail

GSK recently announced that the consumer healthcare company from its proposed transaction with Pfizer will be named Haleon. Haleon will be a new world leader in consumer healthcare, offering to bring...